Étude d'utilisation de l'acide nicotinique a libération prolongée en France chez des patients en prévention secondaire sous statine avec persistance d'un taux bas de HDL-c

Expected efficacy results were obtained, especially with a very significant increase in HDL-c. The adjunction of prolonged-release nicotinic acid in high risk patients on statin treatment as secondary prevention and with low HDL-c constitutes an interesting strategy.